[Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment].
Chiffoleau
Anne
A
Trochu
Jean-Noël
JN
Veyrac
Gwenaëlle
G
Petit
Thierry
T
Abadie
Patrick
P
Bourin
Michel
M
Jolliet
Pascale
P
D002121:Calcium Channel Blockers / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects*; D004347:Drug Interactions; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000503:physiopathology; D019821:Simvastatin / Q000009:adverse effects*; D014700:Verapamil / Q000009:adverse effects*
D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019821:Simvastatin; D014700:Verapamil